Contribution of (1→3)-β- d -Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Two noninvasive diagnostic tests, (1→3)-β- d -glucan (BG) (Glucatell) and galactomannan (GM) (Platelia Aspergillus ), were used retrospectively in a twice-weekly screening for the diagnosis of invasive aspergillosis (IA) in 40 treatment episodes (one hospital visit per patient) in 40 neutropenic adult patients at high risk for IA. Five proven IA cases, three probable IA cases, and three possible IA cases were diagnosed. Diagnostic levels of both BG and GM were detected in 100% of patients with proven IA cases and in 66% of patients with probable IA cases. The kinetics of both markers in patients with IA were similar. The sensitivity, specificity, and positive and negative predictive values for GM and BG were identical, namely, 87.5, 89.6, 70, and 96.3%, respectively. False-positive reactions occurred at a rate of 10.3% in both tests, but the patients showing false-positive results were different in each test. Both tests anticipated the clinical diagnosis, computed tomography abnormalities, and the initiation of antifungal therapy in most patients, but BG tended to become positive earlier than GM. A combination of the two tests improved the specificity (to 100%) and positive predictive value (to 100%) of each individual test without affecting the sensitivity and negative predictive values. In conclusion, BG and GM detection are useful tests for the diagnosis of IA in high-risk hematological patients, but a combination of the two tests was very useful to identify false-positive reactions by each test.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642
Bangsberg, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/507526 · Cited by 534
Obayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
The Impact of Culture Isolation of Aspergillus Species: A Hospital‐Based Survey of Aspergillosis
Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W., Stevens, D. A., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/323900 · Cited by 458 · cited 2×
“In recent years, the detection of different circulating surrogate markers such as fungal cell wall components (BG and GM) and genomic fungal DNA have emerged and improved the diagnosis of IA (5, 13, 20, 26, 28).”
BackgroundMaertens, J., Verhaegen, J., Demuynck, H., Brock, P., Verhoef, G., Vandenberghe, P., Van Eldere, J., Verbist, L., & Boogaerts, M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3223-3228.1999 · Cited by 376
Pulmonary Aspergillosis: Early Diagnosis Improves Survival
von Eiff, M., Roos, N., Schulten, R., Hesse, M., Zühlsdorf, M., & van de Loo, J. (1995) · Respiration · doi:10.1159/000196477 · Cited by 351
Maertens, J., Van Eldere, J., Verhaegen, J., Verbeken, E., Verschakelen, J., & Boogaerts, M. (2002) · The Journal of Infectious Diseases · doi:10.1086/343804 · Cited by 343
Kawazu, M., Kanda, Y., Nannya, Y., Aoki, K., Kurokawa, M., Chiba, S., Motokura, T., Hirai, H., & Ogawa, S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2733-2741.2004 · Cited by 280
Denning, D. W., Marinus, A., Cohen, J., Spence, D., Herbrecht, R., Pagano, L., Kibbler, C., Kermery, V., Offner, F., Cordonnier, C., et al. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80173-4 · Cited by 256
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kähkölä, P., & Ruutu, T. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700737 · Cited by 251
Sulahian, A., Boutboul, F., Ribaud, P., Leblanc, T., Lacroix, C., & Derouin, F. (2001) · Cancer · doi:10.1002/1097-0142(20010115)91:2<311::aid-cncr1003>3.0.co;2-3 · Cited by 226
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan
Swanink, C. M., Meis, J. F., Rijs, A. J., Donnelly, J. P., & Verweij, P. E. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.257-260.1997 · Cited by 222
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Sulahian, A., Tabouret, M., Ribaud, P., Sarfati, J., Gluckman, E., Latgé, J. P., & Derouin, F. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01591487 · Cited by 183
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
Prentice, H. G., Kibbler, C. C., & Prentice, A. G. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02014.x · Cited by 181
Boutboul, F., Alberti, C., Leblanc, T., Sulahian, A., Gluckman, E., Derouin, F., & Ribaud, P. (2002) · Clinical Infectious Diseases · doi:10.1086/339324 · Cited by 179
Denning, D. W., Evans, E. G. V., Kibbler, C. C., Richardson, M. D., Roberts, M. M., Rogers, T. R., Warnock, D. W., & Warren, R. E. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02471906 · Cited by 163
Verweij, P. E., Latgé, J. P., Rijs, A. J., Melchers, W. J., De Pauw, B. E., Hoogkamp-Korstanje, J. A., & Meis, J. F. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3150-3153.1995 · Cited by 162
Digby, J., Kalbfleisch, J., Glenn, A., Larsen, A., Browder, W., & Williams, D. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153
Bretagne, S., Marmorat‐Khuong, A., Kuentz, M., Latgé, J., Bart–Delabesse, E., & Cordonnier, C. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)90833-1 · Cited by 129
Kami, M., Tanaka, Y., Kanda, Y., Ogawa, S., Masumoto, T., Ohtomo, K., Matsumura, T., Saito, T., Machida, U., Kashima, T., et al. (2000) · PubMed · Cited by 104
Subirá, M., Martino, R., Rovira, M., Vázquez, L., Serrano, D., & de la Cámara, R. (2003) · Annals of Hematology · doi:10.1007/s00277-002-0599-4 · Cited by 92
Endotoxin-inactivating activity in normal and pathological human blood samples
Obayashi, T., Tamura, H., Tanaka, S., Ohki, M., Takahashi, S., & Kawai, T. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.294-297.1986 · Cited by 92
Verweij, P. E., Meis, J. F. G. M., Dompeling, E., Donnelly, J. P., & Schattenberg, A. (1997) · Infection · doi:10.1007/bf02113581 · Cited by 79
Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke, M., & Maschmeyer, G. (2002) · PubMed · Cited by 71
García-Ruiz, J. C., del Carmen Arilla, M., Regúlez, P., Quindós, G., Alvarez, A., & Pontón, J. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3284-3287.1997 · Cited by 61
Efficiency of Seroiogic Tests in the Diagnosis of Systemic Candidiasis
Kozinn, P. J., Taschdjian, C. L., Goldberg, P. K., Protzman, W. P., Mackenzie, D. W. R., Remington, J. S., Anderson, S., & Seelig, M. S. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/70.6.893 · Cited by 50
Impact of diagnostic markers on early antifungal therapy
Jones, B., & McLintock, L. A. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00002 · Cited by 39
Pazos, C., & del Palacio, A. (2003) · PubMed · Cited by 28
Self-citationThe challenge of invasive aspergillosis: Increasing numbers in diverse patient groups
Verweij, P. E., & Denning, D. W. (1997) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(97)90083-7 · Cited by 23
[Laboratory diagnosis of invasive aspergillosis].
del Palacio, A., Cuétara, M. S., & Pontón, J. (2003) · PubMed · Cited by 19
Self-citationSakai, T., Ikegami, K., Yoshinaga, E., Uesugi-Hayakawa, R., & Wakizaka, A. (2000) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.190.119 · Cited by 17
Cited by
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 752
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Metadata
- Authors
- Pazos, C., Pontón, J., & Palacio, A. D.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2005-01
- Volume
- 43
- Issue
- 1
- Pages
- 299-305
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2128856844
- Cited by
- 337
- References
- 37
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.